Robert P. Kustra

885 total citations
20 papers, 677 citations indexed

About

Robert P. Kustra is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Genetics. According to data from OpenAlex, Robert P. Kustra has authored 20 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pediatrics, Perinatology and Child Health, 13 papers in Psychiatry and Mental health and 3 papers in Genetics. Recurrent topics in Robert P. Kustra's work include Epilepsy research and treatment (13 papers), Pharmacological Effects and Toxicity Studies (12 papers) and Hemoglobinopathies and Related Disorders (3 papers). Robert P. Kustra is often cited by papers focused on Epilepsy research and treatment (13 papers), Pharmacological Effects and Toxicity Studies (12 papers) and Hemoglobinopathies and Related Disorders (3 papers). Robert P. Kustra collaborates with scholars based in United States, Netherlands and Australia. Robert P. Kustra's co-authors include Anne E. Hammer, Joyce A. Cramer, John A. Messenheimer, Alan B. Ettinger, Kimford J. Meador, A. James Fessler, P. G. Ray, James M. Miller, David W. Loring and Mary Ann Werz and has published in prestigious journals such as Neurology, Journal of the American Society of Nephrology and The Journal of Pediatrics.

In The Last Decade

Robert P. Kustra

19 papers receiving 651 citations

Peers

Countries citing papers authored by Robert P. Kustra

Since Specialization

Citations

This map shows the geographic impact of Robert P. Kustra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert P. Kustra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert P. Kustra more than expected).

Fields of papers citing papers by Robert P. Kustra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert P. Kustra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert P. Kustra. The network helps show where Robert P. Kustra may publish in the future.

Co-authorship network of co-authors of Robert P. Kustra

This figure shows the co-authorship network connecting the top 25 collaborators of Robert P. Kustra. A scholar is included among the top collaborators of Robert P. Kustra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert P. Kustra. Robert P. Kustra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fracture events in patients with primary biliary cholangitis during treatment with seladelpar in the phase III RESPONSE trial 2025 ·Hepatology Communications ·John M. Vierling, Gideon M. Hirschfield, Robert P. Kustra, (unknown), (unknown), Daria B. Crittenden	0
2	Selonsertib in Patients with Diabetic Kidney Disease 2024 ·Journal of the American Society of Nephrology ·Hiddo J.L. Heerspink, Vlado Perkovic, Katherine R. Tuttle, Pablo E. Pérgola, Kenneth W. Mahaffey, Uptal D. Patel, Julie H. Ishida, Albert Y. Kuo, Chen Fang, Robert P. Kustra, (unknown), Peter Rossing, Naoki Kashihara, Glenn M. Chertow	6
3	A Phase 2b Randomized Controlled Trial of Selonsertib in Moderate to Severe Diabetic Kidney Disease (MOSAIC) 2022 ·Journal of the American Society of Nephrology ·Vlado Perkovic, Katherine R. Tuttle, Pablo E. Pérgola, Kenneth W. Mahaffey, Uptal D. Patel, Julie H. Ishida, Chen Fang, Gerald Crans, Robert P. Kustra, (unknown), Hiddo J.L. Heerspink, Peter Rossing, Naoki Kashihara, Glenn M. Chertow	1
4	Subjective perception of cognition is related to mood and not performance 2009 ·Epilepsy & Behavior ·Susan E. Marino, Kimford J. Meador, David W. Loring, Michael S. Okun, Hubert H. Fernandez, A. James Fessler, Robert P. Kustra, James M. Miller, P. G. Ray, (unknown), Mike R. Schoenberg, Victoria Vahle, Mary Ann Werz	93
5	Cognitive effects of lamotrigine versus topiramate as adjunctive therapy in older adults with epilepsy 2009 ·Neurology International ·Steve Chung, (unknown), (unknown), Robert P. Kustra	10
6	Depressive Symptoms in Epilepsy 2008 ·Drugs ·(unknown), Robert P. Kustra, Alain Vuong, Anne E. Hammer, John A. Messenheimer	49
7	Relative influences of adjunctive topiramate and adjunctive lamotrigine on scanning and the effective field of view 2007 ·Epilepsy Research ·Kenneth C. Mills, Joseph F. Drazkowski, Anne E. Hammer, Paul T. Caldwell, Robert P. Kustra, David Blum	9
8	Assessment of tolerability in elderly patients: Changing to lamotrigine therapy 2007 ·The American journal of geriatric pharmacotherapy ·Bradley K. Evans, Robert P. Kustra, Anne E. Hammer	10
9	Conversion to lamotrigine monotherapy from valproate monotherapy in older adolescent patients with epilepsy 2007 ·Current Medical Research and Opinion ·Robert J. Baumann, Toufic Fakhoury, Robert P. Kustra, Alain Vuong, Anne E. Hammer, John A. Messenheimer	5
10	Epilepsy and women’s health issues: Unmet needs—Survey results from women with epilepsy 2006 ·Epilepsy & Behavior ·Blanca Vázquez, Patricia Gibson, Robert P. Kustra	37
11	Effect of lamotrigine on depressive symptoms in adult patients with epilepsy 2006 ·Epilepsy & Behavior ·Alan B. Ettinger, Robert P. Kustra, Anne E. Hammer	56
12	Lamotrigine therapy in patients requiring a change in antiepileptic drug regimen 2005 ·Seizure ·Robert P. Kustra, Kimford J. Meador, Bradley K. Evans, (unknown), (unknown), Anne E. Hammer, Kevin P. Nanry, John A. Messenheimer	8
13	Effects of lamotrigine monotherapy in patients with newly diagnosed juvenile myoclonic epilepsy: An open-label study 2005 ·Current Therapeutic Research ·(unknown), Anne E. Hammer, Robert P. Kustra, John A. Messenheimer	5
14	Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers 2005 ·Neurology ·Kimford J. Meador, David W. Loring, Victoria Vahle, P. G. Ray, Mary Ann Werz, A. James Fessler, Paula Ogrocki, Mike R. Schoenberg, James M. Miller, Robert P. Kustra	110
15	Improved mood states with lamotrigine in patients with epilepsy 2004 ·Epilepsy & Behavior ·Joyce A. Cramer, Anne E. Hammer, Robert P. Kustra	38
16	Quality of life improvement with conversion to lamotrigine monotherapy 2004 ·Epilepsy & Behavior ·Joyce A. Cramer, Anne E. Hammer, Robert P. Kustra	46
17	Lamotrigine for patients with juvenile myoclonic epilepsy following prior treatment with valproate: results of an open-label study 2004 ·Epilepsy & Behavior ·George L. Morris, Anne E. Hammer, Robert P. Kustra, John A. Messenheimer	43
18	Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: A randomized placebo‐controlled study 2001 ·Clinical Pharmacology & Therapeutics ·David Gonzales, Mitchell Nides, Linda Hyder Ferry, Robert P. Kustra, Brenda D. Jamerson, Nathan Segall, L. Herrero, Alok Krishen, (unknown), (unknown), Alan Metz	112
19	The pharmacokinetics of ibuprofen suspension, chewable tablets, and tablets in children with cystic fibrosis 1999 ·The Journal of Pediatrics ·(unknown), George Retsch‐Bogart, Robert P. Kustra, (unknown), (unknown), Philip C. Smith	24
20	Lack of Effect of Cimetidine on the Pharmacokinetics of Sustained‐Release Bupropion 1999 ·The Journal of Clinical Pharmacology ·Robert P. Kustra, Brian Corrigan, John A. Dunn, Benjamin Duncan, Poe‐Hirr Hsyu	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact